Fomenko et al., 2014 - Google Patents
Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damageFomenko et al., 2014
View PDF- Document ID
- 4885047543668897875
- Author
- Fomenko I
- Sklyarov A
- Bondarchuk T
- Biletska L
- Panasyuk N
- Wallace J
- Publication year
- Publication venue
- Stress
External Links
Snippet
Mechanisms of gastric defence under conditions of combined influence of acute stress and non-steroidal anti-inflammatory drugs (NSAIDs) are still poorly studied. The aim of this study was to explore the effects of different types of NSAIDs (naproxen, celecoxib and ATB-346) in …
- 230000002496 gastric 0 title abstract description 110
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-arylpropionic acids, ethacrynic acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fomenko et al. | Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage | |
Chan et al. | Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments | |
Wang et al. | The role of H2S bioavailability in endothelial dysfunction | |
Paul et al. | H2S signalling through protein sulfhydration and beyond | |
Zaorska et al. | Hydrogen sulfide in pharmacotherapy, beyond the hydrogen sulfide-donors | |
Yu et al. | Melatonin ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1α-SIRT3 signaling | |
Xu et al. | Nitric oxide: orchestrating hypoxia regulation through mitochondrial respiration and the endoplasmic reticulum stress response | |
Matera et al. | Oxidation pathway and exacerbations in COPD: the role of NAC | |
Blackler et al. | Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence | |
Waseem et al. | Cisplatin hepatotoxicity mediated by mitochondrial stress | |
Zanardo et al. | Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation | |
Zhang et al. | Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases | |
Whiteman et al. | Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising | |
Flannigan et al. | Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis | |
Cheng et al. | Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats | |
Nguyen et al. | Dual COX and 5-LOX inhibition by clerodane diterpenes from seeds of Polyalthia longifolia (Sonn.) Thwaites | |
Sezgin et al. | Protective effect of melatonin and 1, 25-dihydroxyvitamin D3 on renal ischemia–reperfusion injury in rats | |
Garrabou et al. | Mitochondrial injury in human acute carbon monoxide poisoning: the effect of oxygen treatment | |
Magierowska et al. | Carbon monoxide (CO) released from tricarbonyldichlororuthenium (II) dimer (CORM-2) in gastroprotection against experimental ethanol-induced gastric damage | |
Kimura et al. | Sulfite protects neurons from oxidative stress | |
Chattopadhyay et al. | Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH‐naproxen (AVT‐219) a dual NO‐and H2S‐releasing hybrid | |
Fiorucci et al. | Activation of the farnesoid‐X receptor protects against gastrointestinal injury caused by non‐steroidal anti‐inflammatory drugs in mice | |
Xu et al. | Statins upregulate cystathionine γ-lyase transcription and H2S generation via activating Akt signaling in macrophage | |
Sarna et al. | The CBS/CSE system: a potential therapeutic target in NAFLD? | |
Popov | An outlook on vascular hydrogen sulphide effects, signalling, and therapeutic potential |